Ian F. Smith - 03 Jan 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Director Stock Option (Right to Buy)	Award	$0	+195K		$0.00	195K	03 Jan 2022	Common Stock	195K	$1.78	Direct	F1
transaction	SLDB	Restricted Stock Units	Award	$0	+97.3K		$0.00	97.3K	03 Jan 2022	Common Stock	97.3K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted on January 3, 2022 pursuant to a services agreement between the reporting person and the Issuer and will vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the option will accelerate in full.
F2	Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.
F3	The restricted stock units were granted on January 3, 2022 and vest on the same schedule as set forth in footnote (1) above.